Precision Medicine Software Market Report: Company Analysis, History and Future Overview

1. Precision Medicine Software Market Precision Medicine Software Market Report: Company Analysis, History and Future Overview, Global Sales Trends by 2025 www.qyrconsulting.com

2. The global precision medicine software market is forecast to gain growth on the back of increasing application of such software in the diagnosis of infectious diseases and screening of prenatal aneuploidy. Vendors are expected to introduce innovative solutions in the global market to expand their customer base. Some of them are anticipated to focus on establishing new facilities in emerging economies to bank on key growth opportunities. Developing partnerships with healthcare companies could be one of the most common strategies adopted in the global market. In July 2019, Syapse, a US developer of cloud-based data medical software, strategically collaborated with Pfizer to advance cancer outcomes research by generating insights from real-world evidence. In May 2019, Syapse formed a precision medicine collaboration with Amgen, a US-based multinational biopharmaceutical company. Rising Incidence of Cancer to Increase Need for Precision Medicine Software Growing requirement of precision medicine for cancer treatment is prophesied to largely contribute to the growth of the global precision medicine software market. Besides high prevalence of cancer, other factors such as growing number of collaborations and partnerships between healthcare IT companies and healthcare institutions could increase the need for precision medicine software. One of the crucial factors augmenting the demand for precision medicine software is the need to predict long-term prognosis and measure patient outcome. High use of precision medicine software to identify therapeutic targets in neoplasms is expected to push the demand in the global market.

3. Vendors to Partner with Health Systems to Make Precision Medicine More Accessible • The report includes company profiling of important players of the global precision medicine software market such as Syapse, Inc., Fabric Genomics, Inc., Translational Software Inc., SOPHiA GENETICS SA, N-of-One Inc. (a subsidiary of Qiagen N.V.), Human Longevity, Inc., Gene42 Inc., Sunquest Information Systems, Inc., PierianDx Inc., LifeOmic, Foundation Medicine Inc., and 2bPrecise LLC. • Get PDF Template: https://www.qyrconsulting.com/request-sample/7343 • By Delivery Mode • ●   Cloud-based • ●   On-premise • By Application • ●   Rare Diseases • ●   Oncology • ●   Pharmacogenomics • By End User • ●   Healthcare Providers • ●   Pharmaceutical and Biotechnology Companies

4. By Region Regionally, North America is prognosticated to exhibit telling growth in the global precision medicine software market, taking into consideration its high investments in healthcare IT. Promising government funding and significant adoption of digitalization in the US and Canada are expected to strengthen the growth of the North America market. Researchers also anticipate the implementation of stringent healthcare policies and regulatory mandates to positively impact the market growth in North America.Report TOC, Figures and Tables: https://www.qyrconsulting.com/reports/precision-medicine-software-market

5. RESEARCH METHODOLOGY SUPPLY SIDE • DATABASE MACROECONOMIC • INSIGHT • In-depth interview Data Mining & Handling Build Connection Data Verification • Interviews of: • Manufacturers, Distributor, Opinion Leaders, Industry Experts, Front-line Staff, Directors, CEO, Marketing Executives, Technology, Innovation Directors and • Executives from Related Industries and Organizations • Through interviews, research analysts collect & sort data and establishes research models. • Secondary Sources: • Annual Reports, Presentations, Press Releases, Journals, Paid Databases • All possible demand side factors that influence the markets: Effect of inflation, economic downturns, and changed regulations & policy or other factors • Market Size is validated through Primary Sources and Secondary Sources Establishing point to point products and capital flows within the chain

6. RESEARCH APPROACH Date Source: Our Secondary Data Sources 70% of the data has collected from the first-hand information Secondary sources occupies approximately of the overall sources 30%

7. OUR SERVICES Market Research Strategy and Plan Customized Service • Market status and forecast • Competitive landscape • Price fluctuation monitor • Marketing channel analysis • Startup capability evaluation • Target market analysis & Strategy set up • Local Buyer/Partner matching • Tailored market research • 200+ full time experienced analyst • Continuous after-sales service Business Consulting Press Release Expert Network • Due diligence • IPO counseling • Legal advice • customer service • Market M&A news • Advertising • Tracking industry policy and interpretation 2000+ experts in each territory Cutting-edge technology seminar

8. OUR CLIENT

9. DISCLAIMER The information and opinions in this report were prepared by QYR Consulting. The information herein is believed to be reliable and has been obtained from authentic public sources. QYR Consulting research and analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that QYR Consulting research and analysis services are for our customers’ internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. QYR Consulting does not endorse any vendors, product or service depicted in their research publications. QYR Consulting research and analysis publications consist of the opinions of QYR Consulting’s research and should not be construed as statements of fact. QYR Consulting disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. QYR Consulting takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. © Copyright © 2007-2026 QYR Consulting. All rights reserved This document contains highly confidential information and is the sole property of QYR Consulting. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of QYR Consulting.

10. Thanks for reading, for any question, please feel free to contact the QYR Consulting Center analyst www.qyrconsulting.com CONTACT US China : +86 108 294 5717 USA : +1 626 428 8800 India : +91 20 67104444 sales@qyrconsulting.com